Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the study-record error page.SummaryDifference0.3%

- Check12 days agoChange DetectedThe footer now identifies the site release as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study content with a generic error screen and site header/footer. This indicates restricted access to the page rather than changes to the study record text.SummaryDifference21%

- Check54 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This appears to be a minor deployment update rather than a substantive change to study details or page content.SummaryDifference0.1%

- Check69 days agoChange DetectedMiST study page now shows the trial is completed and no longer recruiting, with results posted (including 12- and 24-week disease control rate and objective response rate). It also adds several study documents and protocol PDFs to the page.SummaryDifference4%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small update to the study record on ClinicalTrials.gov. This change does not alter core study content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.